Accueil>>Signaling Pathways>> Immunology/Inflammation>> Complement System>>(Z)-Leukadherin-1

(Z)-Leukadherin-1 (Synonyms: ADH-503 free base)

Catalog No.GC38880

La (Z)-leukadhérine-1 (base libre ADH-503) est un agoniste CD11b actif par voie orale et allostérique. La (Z)-leukadhérine-1 entraÎne la repolarisation des macrophages associés À la tumeur, la réduction du nombre de cellules myéloÏdes immunosuppressives infiltrant la tumeur et améliore les réponses des cellules dendritiques.

Products are for research use only. Not for human use. We do not sell to patients.

(Z)-Leukadherin-1 Chemical Structure

Cas No.: 2055362-72-4

Taille Prix Stock Qté
Free Sample (0.1-0.5 mg) Please Inquire Please Inquire
5mg
50,00 $US
En stock
10mg
81,00 $US
En stock
50mg
225,00 $US
En stock
100mg
315,00 $US
En stock
200mg Please Inquire Please Inquire
500mg Please Inquire Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

(Z)-Leukadherin-1 (ADH-503 free base) is an orally active and allosteric CD11b agonist. (Z)-Leukadherin-1 leads to the repolarization of tumorassociated macrophages, reduction in the number of tumor-infiltrating immunosuppressive myeloid cells, and enhances dendritic cell responses[1].

(Z)-Leukadherin-1 (ADH-503 free base; 4 μM; 8 days) reduces the numbers of total tumor-infiltrating CD11b+ cells and subsets of CD11b+ monocytes, granulocytes, eosinophils, and macrophages[1].

(Z)-Leukadherin-1 (ADH-503 free base; oral gavage; 30, 60, or 120 mg/kg; twice a day for 60 days) delayes tumor progression, leading to a significantly decreased tumor burden in time-point analysis and improved overall survival[1]. (Z)-Leukadherin-1 (oral gavage; 30, 100 mg/kg; twice a day; on days 1 and 5) has the mean half-life of 4.68 and 3.95 hours, a maximum concentration of 1716 and 2594 ng/ml and AUC0-t in the plasma of 6950 and 13962 ng.h/ml at 30 and 100 mg/kg dosing, respectively[1]. Animal Model: KPC mice [p48-CRE/Lox-stop-Lox(LSL)-KrasG12D/p53flox/flox][1]

[1]. Panni RZ, et al. Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies. Sci Transl Med. 2019 Jul 3;11(499).

Avis

Review for (Z)-Leukadherin-1

Average Rating: 5 ★★★★★ (Based on Reviews and 19 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for (Z)-Leukadherin-1

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.